Nanosphere Commences Public Offering | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Nanosphere announced after the close of the market on Monday that it intends to offer 13.6 million shares of its common stock in a public offering.

The shares will be priced at $2.20 per share and Nanosphere expects proceeds from the offering to be about $27.9 million. If the underwriters exercise their over-allotment option in full, net proceeds will be about $32.1 million, it added.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: variation patterns in wheat lines, regulatory variation in Capsella grandiflora, and more.

A Rockefeller University researcher is using edited ants to explore complex biological systems, the New York Times writes.

There's a heritable aspect to how much time people spend online, the Los Angeles Times reports.

Stat News reports that Joseph Gulfo is another contender for FDA commissioner.